CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
MAIDENHEAD NEWINCCO 1096 LIMITED

Hellopages » Berkshire » Windsor and Maidenhead » SL6 4AY

Company number 07596438
Status Active
Incorporation Date 7 April 2011
Company Type Private Limited Company
Address 70 NORDEN ROAD, MAIDENHEAD, BERKSHIRE, SL6 4AY
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration fifty-seven events have happened. The last three records are Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ; Register inspection address has been changed to 7 Albemarle Street London W1S 4HQ; Confirmation statement made on 24 November 2016 with updates. The most likely internet sites of CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED are www.convergencepharmaceuticalsholdings.co.uk, and www.convergence-pharmaceuticals-holdings.co.uk. The predicted number of employees is 1 to 10. The company’s age is fourteen years and eight months. Convergence Pharmaceuticals Holdings Limited is a Private Limited Company. The company registration number is 07596438. Convergence Pharmaceuticals Holdings Limited has been working since 07 April 2011. The present status of the company is Active. The registered address of Convergence Pharmaceuticals Holdings Limited is 70 Norden Road Maidenhead Berkshire Sl6 4ay. . MILL, Trevor Anthony is a Director of the company. TATE, Simon Nicholas is a Director of the company. WATSON, David John is a Director of the company. Secretary REYNOLDS, Brenda Elizabeth has been resigned. Secretary OLSWANG COSEC LIMITED has been resigned. Director ASTON, John Christopher has been resigned. Director ASTON, John Christopher has been resigned. Director BINGHAM, Catherine Elizabeth has been resigned. Director DIX, Clive James has been resigned. Director HOLLOWOOD, Christopher, Dr has been resigned. Director MACKIE, Christopher Alan has been resigned. Director MARCHINGTON, Allan Patrick, Dr has been resigned. Director RATCLIFFE, Liam Thomas, Dr has been resigned. Director OLSWANG DIRECTORS 1 LIMITED has been resigned. Director OLSWANG DIRECTORS 2 LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
MILL, Trevor Anthony
Appointed Date: 11 February 2015
54 years old

Director
TATE, Simon Nicholas
Appointed Date: 17 June 2011
59 years old

Director
WATSON, David John
Appointed Date: 11 February 2015
53 years old

Resigned Directors

Secretary
REYNOLDS, Brenda Elizabeth
Resigned: 11 February 2015
Appointed Date: 17 June 2011

Secretary
OLSWANG COSEC LIMITED
Resigned: 17 June 2011
Appointed Date: 07 April 2011

Director
ASTON, John Christopher
Resigned: 11 February 2015
Appointed Date: 01 November 2013
71 years old

Director
ASTON, John Christopher
Resigned: 01 November 2013
Appointed Date: 01 November 2013
71 years old

Director
BINGHAM, Catherine Elizabeth
Resigned: 11 February 2015
Appointed Date: 26 October 2011
60 years old

Director
DIX, Clive James
Resigned: 11 February 2015
Appointed Date: 17 June 2011
71 years old

Director
HOLLOWOOD, Christopher, Dr
Resigned: 31 August 2012
Appointed Date: 26 October 2011
50 years old

Director
MACKIE, Christopher Alan
Resigned: 17 June 2011
Appointed Date: 07 April 2011
65 years old

Director
MARCHINGTON, Allan Patrick, Dr
Resigned: 05 February 2015
Appointed Date: 25 July 2012
59 years old

Director
RATCLIFFE, Liam Thomas, Dr
Resigned: 05 February 2015
Appointed Date: 26 October 2011
62 years old

Director
OLSWANG DIRECTORS 1 LIMITED
Resigned: 17 June 2011
Appointed Date: 07 April 2011

Director
OLSWANG DIRECTORS 2 LIMITED
Resigned: 17 June 2011
Appointed Date: 07 April 2011

Persons With Significant Control

Silver Acquisition Co Limited
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more

CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED Events

12 Apr 2017
Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ
12 Apr 2017
Register inspection address has been changed to 7 Albemarle Street London W1S 4HQ
01 Dec 2016
Confirmation statement made on 24 November 2016 with updates
10 Nov 2016
Full accounts made up to 31 December 2015
17 Dec 2015
Annual return made up to 24 November 2015 with full list of shareholders
Statement of capital on 2015-12-17
  • GBP 22,043.4425

...
... and 47 more events
04 Jul 2011
Change of name notice
04 Jul 2011
Current accounting period extended from 30 April 2012 to 30 September 2012
01 Jul 2011
Appointment of Simon Nicholas Tate as a director
01 Jul 2011
Appointment of Brenda Elizabeth Reynolds as a secretary
07 Apr 2011
Incorporation